ArticleCureus2025
Herlyn-Werner-Wunderlich (HWW) Syndrome in an Adolescent.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Long-Term Management and Prevention Strategies for Adolescent Primary Dysmenorrhea: From Precision Diagnosis to Comprehensive Intervention.International journal of women's health · 2026Review
- Case Report: Soft endoscopic treatment of Herlyn-Werner-Wunderlich syndrome: an innovative clinical procedure for hymen preservation.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herlyn-Werner-Wunderlich (HWW) syndrome, also known as obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome, is a rare Müllerian duct anomaly characterized by the triad of uterus didelphys, obstructed hemivagina, and ipsilateral renal agenesis. Early diagnosis is essential to prevent complications and preserve reproductive potential. We report the case of a 14-year-old female patient with significant dysmenorrhea and menstrual irregularities since menarche. The initial pelvic ultrasound was unremarkable. Nine months later, she presented repeatedly to the emergency department with left flank pain and vomiting. Further evaluation revealed the absence of the left kidney, uterus didelphys with an obstructed left hemi-uterus, hematocolpos, hematosalpinx, left ovarian endometrioma, and left renal agenesis on magnetic resonance imaging (MRI). Surgical management included laparoscopic hemihysterectomy of the left uterus and ipsilateral salpingectomy. Postoperatively, the patient was started on continuous progestogen-only therapy, with marked improvement in symptoms and quality of life. HWWsyndrome typically manifests soon after menarche with cyclic pelvic pain, dysmenorrhea refractory to treatment, or pelvic mass. MRI is the gold standard for diagnosis, allowing precise anatomical characterization and guiding surgical planning. Without a functional or communicating obstructed hemicavity, hemihysterectomy with salpingectomy is an effective approach, preventing recurrence and reducing the risk of complications such as infection and endometriosis. This case highlights the importance of maintaining a high index of suspicion for HWW syndrome in adolescents with refractory dysmenorrhea and associated renal anomalies. Early diagnosis and individualized surgical management can relieve symptoms, improve quality of life, and preserve reproductive potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.